Cointime

Auxilium Pharmaceuticals

company

About

Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual

  • 501 - 1000

Highlights

Total Funding Amount
$43M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series D
Last Funding Money Raised
$43M
Industries
Biotechnology,Health Care,Market Research,Pharmaceutical
Founded date
Jan 1, 1999
Number Of Employee
501 - 1000
Operating Status
Active

Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle, Auxilium’s mission has expanded to include the development and marketing of novel treatment options for many of society’s unmet medical needs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$43M
Auxilium Pharmaceuticals has raised a total of $43M in funding over 2 rounds. Their latest funding was raised on Nov 7, 2003 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 7, 2003 Series D $43M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Auxilium Pharmaceuticals is funded by 1 investors. Perseus-Soros Biopharmaceutical Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Perseus-Soros Biopharmaceutical Fund — Series D
Cointime
เนื้อหา
บริษัท